27 May 2020 12:00 PM (AEST) Please join your host A/Professor Dr Edwina Wright, Infectious Diseases Specialist in the Department of Infectious Diseases, Alfred Hospital and ASHM COVID-19 Taskforce Chair and Professor Damian Purcell, Head of the Molecular Virology Laboratory in the Department of Microbiology and Immunology at the Peter Doherty Institute and Dr James McMahon, Head of Clinical Research Unit at the Alfred Hospital, Infectious Diseases Physician at Alfred Health and Monash Health, and Maddy, a person recovered from COVID-19 infection, as they discuss what we currently know about SARs-COV-2 virus; its infection and illness implications and impact on…

25 May 2020 4:00pm (AEST) How has COVID-19 impacted viral hepatitis services across Asia and the Pacific, and how can services respond to the changing needs of the community? Join us for a discussion on the implication of COVID-19 on viral hepatitis as we talk to clinicians and community members from across Asia and the Pacific about their experiences. Speakers: Professor Saeed Hamid, CEVHAP Co-chair, Dr Po-Lin Chan, WHO Western Pacific Regional Office, Lien Tran, PhD scholar, viral infectious diseases, The Doherty Institute, and Other special guests. Register here.

3 June 2020 7:00pm - 8:30pm (WST) Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) are holding a free webinar for Primary Care providers to increase your knowledge in the role of hepatitis C treatment and cure in Primary Care. The goal in Australia is to eliminate Hepatitis C in Australia by 2030, and primary care providers will play a critical role in achieving this goal. Register for the free webinar on Wednesday June 3rd 2020 at 7.00pm AWST here.

Tuesday 26 May 2020 8:00pm (AEST) Disaster Planning during the COVID-19 pandemic. Dr Adam Coltzau will host a panel including Professor Brendan Murphy (Chief Medical Officer), Shane Fitzsimmons (Commissioner of Resillience NSW and Deputy Secretary Emergency Management) and Dr Tim Leeuwenburg (FACRRM and RG Anaesthetist with acute care experience in retrieval and austere environment medicine). Register here.

Tuesday 26 May 12:00pm-1:00pm (AEST) This Digital Health CRC, Curtin University and La Trobe University webinar will offer their perspectives on telehealth and digital patient education in both pre and post COVID-19 contexts. Register here.

Tuesday 16th June 2020 7:00pm – 8:00 pm (AEST) Professor Paul Van Buynder, Public Health Physician and Infectious Diseases Epidemiologist In this presentation we look at the burden of Invasive Meningococcal Disease in Australia, discuss the rationale and importance of vaccination & vaccine options to prevent Invasive Meningococcal Disease and look at the evidence available currently from use in a real world setting. Learning Objectives: Describe the burden and impact of invasive meningococcal disease Discuss recommendations for meningococcal vaccines Discuss meningococcal B vaccines Understand real world evidence for meningococcal B vaccines Find out more and register here.

Tuesday 9th June 2020 7:00pm – 8:00pm (AEST) Professor David Barnes, Respiratory & Sleep Medicine Physician Learning Objectives: Unmet need in COPD and consequences of late diagnosis and treatment. Treating the predominant trait: ‘Breathlessness’ or ‘Exacerbations’. The role of Trelegy (Fluticasone Furoate/Umeclidinium/Vilanterol) (ICS/LAMA/LABA) for the treatment of moderate to severe COPD and its benefits vs Multiple Inhaler Triple Therapy. Find out more and register here.

Tuesday 2nd June 2020 7:00pm – 8:00pm (AEST) Dr Michael Nissen, Medical Expert, GSK Describing the importance and rationale of updating vaccinations in patients with chronic lung disease and recommending appropriate immunisations. Learning Objectives: Describe the rationale for updating vaccinations in patients with chronic lung disease. Discuss the consequences of under-vaccination in patients with asthma and COPD. Recommend appropriate Immunisations for patients with chronic lung disease. Find out more and register here.

Tuesday 26th May 2020 7:00pm – 8:00pm (AEST) Professor Norbert Berend, Global Medical Expert, GSK This webinar will discuss treatment options including recent developments for patients with moderate and severe asthma. The role of anti-IL5 monoclonal antibodies for the treatment of severe eosinophilic asthma will also be reviewed. Learning Objectives: Understand differences in the real world effectiveness of ICS/LABA medications Discuss the burden of severe asthma including the impact of exacerbations and OCS use Discuss the role of primary care physicians in supporting the identification and post treatment management of severe asthma patients Introduction to Nucala(mepolizumab) including, efficacy, long term…

Tuesday 19th May 2020 7:00pm – 8:00pm (AEST) Professor Norbert Berend, Global Medical Expert, GSK This engaging, case study based webinar will discuss recent research into the management of mild and moderate asthma. Learning Objectives: Understand the importance and benefits of regular ICS based maintenance therapy Identifying when to start regular ICS based maintenance therapy Review of ICS based treatment strategies and recent insights Find out more and register here.